This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceuticalcompanies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceuticalcompanies and patient and caregivers.”.
Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceuticalcompanies, and medical device manufacturers alike. Effective Communication: The foundation of any successful relationship is clear and effective communication.
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. However, the involvement of the company should always be stated.
Here are some factors to consider when choosing a web development company for the pharmaceutical industry: ● Experience in the pharmaceutical industry: Make sure the company you choose has experience developing websites for pharmaceuticalcompanies. Interview multiple companies before making a decision. ●
In this blog, we will briefly explore the challenges and opportunities of digitalized aseptic production, fully contained and automated production and collaborative work with CMOs. Automated systems offer a range of options for pharmaceuticalcompanies. This also results in significant cost savings and increased efficiency.
Trend #1: Media and Tech: Facilitating Communication. The pharmaceutical industry is making it a high priority to be transparent with their audience and help their patients feel as comfortable as possible while getting the care they need. Trend #4: Questioning the Systems: Doubt in Institutions.
Navigating Life Sciences Construction in California Trudy Patterson Thu, 09/28/2023 - 11:40 iSpeak Blog iSpeak Navigating Life Sciences Construction in California Gul Dusi 28 September 2023 Few industries have as deep a footprint in California, USA as life sciences. billion a year.
iSpeak Blog. Applying what has been learned over the last three years to update pharmaceuticalcompanies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Strong and transparent communications and trust are tied to this.
Trudy Patterson Mon, 03/06/2023 - 11:50 iSpeak Blog iSpeak Operations Data Challenges Limit the Value Realized from Pharma 4.0 Michael Krause 6 March 2023 Pharmaceutical and biotech portfolios continue to transition from high volume blockbusters to a diversified set of lower volume, targeted therapeutics.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
The pharmaceutical industry has undergone significant changes in recent years, with digital marketing playing an increasingly important role in the way companiescommunicate with customers and stakeholders.
These technologies enable pharmaceuticalcompanies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinical trials, ultimately accelerating the time-to-market for new therapies. Partnerships and collaborations are gaining traction as innovative marketing strategies in the pharma industry.
Multichannel marketing is an effective digital strategy for pharmaceuticalcompanies to reach consumers and encourage them to purchase products. By utilizing multiple channels such as social media, email, and mobile applications, pharma companies can reach a wider audience and coordinate their efforts to create a unified message.
There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceuticalcompanies to publish their prices in a password protected site on HRSA's website. Four of the five staffers originally involved in the investigation now work for or lobby for the pharmaceutical industry.
As patients become more digitally savvy, pharmaceuticalcompanies can reach them where they are: on social media, search engines, and healthcare websites. Search Engine Optimization (SEO) for Pharma SEO is essential for ranking highly on search engines, and it can be a game-changer for pharmaceutical brands.
Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. It can be a complex and challenging process, as pharmaceuticalcompanies must adhere to strict regulations while also developing creative and effective marketing campaigns.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
Promoting content worldwide When a pharmaceuticalcompany publishes content, it often considers the norms and laws of the country in which it operates. But what if this company decides to expand worldwide? The truth is that MLR reviews are needed in 90% of cases, whether it is a website blog post or an important research paper.
Key Opinion Leaders play a critical role in the life sciences industry – pharmaceuticalcompanies often engage them during clinical trials and drug commercialization. It’s a quantitative way to locate physicians leaders who influence the medical community. In other words, managed KOLs can be a real game-changer.
Medical writing refers to creating healthcare-related textual content that aims to improve doctor-patient communication and provide insights on industry topics. Medical writers must be outstanding communicators, capable of breaking down complex ideas for the public and healthcare professionals in a digestible way.
Just one blog post might be created by the whole team, involving subject-matter experts, marketers, regulatory specialists, and medical writers. Content fragmentation Most departments in many pharma companies still face siloes, which harms content production. Content should be created in accordance with all regulations and standards.
ISPE Advancing Pharmaceutical Quality Program Complete. iSpeak Blog. ISPE Advancing Pharmaceutical Quality Program Complete. ISPE is pleased to announce the complete Advancing Pharmaceutical Quality Program (APQ) Program is now available with the release of the fifth and final guide. Internal Communication.
This may include blog posts, whitepapers, videos, podcasts, or infographics. The most suitable formats for pharma are eDetailers, infographics, case studies , blog posts, articles, and so on. For example, blog articles and social media posts may be most effective during awareness.
Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
RJ Lewis (EHS): So today everybody’s a publisher, part of the beauty of the web and even if you don’t have the technical skills for firing up a website or a blog, which is pretty easy. So whether you’re an advertiser or an event coordinator or a supplier in the industry, most of them have pretty active blogs.
There must be some way to communicate information a little more positively, though. . To require a pharmaceuticalcompany to perform a second randomized clinical trial in another 40,000 patients would be a waste of time and money, especially during a pandemic. Ok, so what did the press release say? variant, either.
I landed on John Mack’s blog, as I’ve done many, many times in the past to look up something. What do you what are you doing with the blog? I didn’t ask them to make a blog about it or anything, go back to the FDA, you thought about wearing the Hawaiian shirt. And he said I’m not sure.
The letter itself is pretty typical of what we would expect to see from OPDP – prioritizing a communication that includes no safety information despite numerous efficacy claims, calling out an efficacy claim as misleading, and failing to submit promotional material on Form 2253. So, what gives?
link] In this insightful blog post, we delve into the diverse facets of Dr. Harris's remarkable career: Holistic Healthcare Visionary : Dr. Harris is not your typical healthcare professional. ⚡️ For more resources to get started, check out some of our other blog post content! And just kind of figure it out on the way.
Pharma’s Challenges to 340B During July and August, several large pharmaceuticalcompanies challenged the operation of the 340B program. For more information on the programs history and a digestable synopsis of the 340B program explained , visit our blog! John Thune (R-S.D.), Debbie Stabenow (D-Mich.),
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content